# Performance Optimization Strategy Specification #18 — Section 9: Approval Checklist

**Created:** May 13, 2026
**Last Updated:** May 13, 2026
**Purpose:** Self-applicable approval checklist. Every row resolves
to either a named, version-controlled file path or a named programmatic
check (per Spec #19 KD-6 programmatic-verification mandate). Rows
binding `[GT]` governance numbers cite the section-file path verbatim
per the §3.10 / §8.4 evidence-artifact convention.

---

## 9.1 Content Checklist

- [ ] All required sections present, including template-slot
      reconciliations:
  - §5 reflexive Test Plan (parallel to Spec #19 §5).
  - §6 CI Orchestration Policy & Triage (replaces template "Performance
    Analysis" — parallel to Spec #19 §6).
  - Evidence: `section-1.md`, `section-2.md`, `section-3.md`,
    `section-4.md`, `section-5.md`, `section-6.md`, `section-7.md`,
    `section-8.md`, `section-9-approval-checklist.md`, `appendices.md`
    all present in `docs/specs/performance-optimization/`.
- [ ] All FR-PO-### present in §2.2 with conformance level, source
      citation, verification pointer (§5.x), and activation stage.
  - Evidence: `section-2.md §2.2` rows; 81 FRs total (FR-PO-001 …
    FR-PO-080 + FR-PO-058a).
- [ ] KD-1 … KD-11 each codified in at least one §3 / §5 / §6
      subsection.
  - Evidence: `section-1.md §1.3` codification map.
- [ ] Boundary statements with #16 §5 / §3.2.4.1 / §3.1 (KD-3 inverted),
      #19 §6 (KD-4), and every per-spec §6 (KD-2) explicit.
  - Evidence: `section-3.md §3.5.3`, `section-3.md §3.8`, `section-5.md
    §5.7`, `section-6.md §6.3`.

## 9.2 Quality Checklist

- [ ] Cite-not-redefine rule audited (no restatements of #16, #19,
      #20, or per-spec §6 rules).
  - Evidence: §5.3 auditor KD-1 pass output (Stage 0: manual review
    notes).
- [ ] Every FR row in §2.2 resolves to a §5.x verification mechanism.
  - Evidence: `section-2.md §2.2` "Verify" column; `section-5.md
    §5.6` traceability table.
- [ ] Every approval-checklist row in *this* checklist cites either a
      file path or a check name (Spec #19 KD-6 self-application via
      Spec #19 §3.5.1, `TBD-NORMATIVE`).
  - Evidence: every row of §9.1 / §9.2 / §9.3 carries an "Evidence:"
    sub-bullet.
- [ ] All cross-references (XC- / FM- / EC- / ERR-) resolve.
  - Evidence: grep against `docs/specs/` for unresolved IDs (manual
    Stage 0; programmatic Stage 0+1).
- [ ] Per-spec §6 schema (Appendix B) present and complete.
  - Evidence: `appendices.md` Appendix B paste-ready template.
- [ ] All `TBD-NORMATIVE`-tagged citations of #16 (KD-3) and #19
      (KD-4) enumerated; outstanding tags listed for the reviewer.
  - Evidence: §8.1.2 (Spec #16 register) and §8.1.3 (Spec #19
    register); both flagged "Status: IN PROGRESS / IN REVIEW" with
    blanket `TBD-NORMATIVE` per status caveat.
- [ ] **Appendix D survey is NOT a #18-approval gate.** The survey of
      #1–#8 / #17 §6 sections is a Stage 0+1 deliverable (§7.2); for
      #18's own approval the requirement is only that Appendix D
      exists with the schema and an empty / partial table. Completing
      the survey rows is deferred so #18's approval is not converted
      into a 9-spec audit task. Parallel to Spec #19 Appendix D scope
      decision.
  - Evidence: `appendices.md` Appendix D headers present; table body
    empty/partial.
- [ ] Governance-number evidence-artifact citations (per §3.10 / §8.4)
      verified — for each `[GT]` value, the cited section-file path
      contains the literal number claimed.
  - Evidence: `section-8.md §8.4` table; auditor confirms literal
    presence at each cited path.

## 9.3 Review Checklist

- [ ] Open issues logged in `CLAUDE.md` "OPEN ISSUES" if any.
  - Evidence: post-draft sweep of `CLAUDE.md` — entry for Spec #18
    transition `IN PROGRESS → IN REVIEW` added.
- [ ] Lead-developer sign-off captured.
  - Evidence: sign-off note appended to §9.4 "Decision" block and to
    `CLAUDE.md` OPEN ISSUES entry.
- [ ] `spec-error-log.md` updated with any cross-spec drift discovered
      during drafting (ERR-018-NNN rows for any per-spec §6 schema
      gaps found).
  - Evidence: `docs/tracking/spec-error-log.md` rows; `ERR-018-001`
    closed atomically with this section file's landing.
- [ ] `SPEC_INDEX.md` status updated atomically with sign-off.
  - Evidence: `docs/specs/SPEC_INDEX.md` row 18 status field.
- [ ] Spec #19's `TBD-NORMATIVE` tags pointing at "Spec #18 §4 / §7"
      preconditions (per Spec #19 KD-3 status caveat) audited: those
      preconditions are this file set (§4 + §7 headers present) —
      confirm #19 reviewer is aware that #18 advancement past `IN
      REVIEW` is symmetric with #18 advancing toward `APPROVED`.
  - Evidence: `testing-strategy/section-1.md §1.4` bidirectional
    sequencing block; #19 reviewer note.
- [ ] `docs/tracking/file-manifest.md` updated to reflect new
      section-file content.
  - Evidence: `file-manifest.md` rows for `performance-optimization/
    section-1.md … section-9-approval-checklist.md` + `appendices.md`
    moved from "stub" to "drafted".

## 9.4 Decision

- **Status:** `IN REVIEW` (author-driven flip; lead-developer review
  pending).
- **Approval evidence:** file paths to programmatically-verifiable
  sources (KD-6 self-application — every row above must comply).
- **Evidence-artifact convention for `[GT]` governance numbers**
  (parallel to Spec #19 §9.4 L5 convention). Per §3.10 / §8.4, each
  governance number's evidence is the section-file citation that
  publishes the number (e.g., `section-3.md §3.5.2` for the +5%
  threshold). Checklist rows pointing at `[GT]` numbers MUST cite the
  section-file path verbatim; the §5.3 auditor (or Spec #19 §5.3
  checklist auditor under #19 KD-6) confirms the literal number is
  present at that path.

### 9.4.1 Outstanding `TBD-NORMATIVE` blockers

Listed here for the reviewer so the cycle to `APPROVED` is explicit:

- Spec #16 `IN PROGRESS` → blocks resolution of #16 citations
  (§3.3.2, §3.3.3, §3.5.3, §3.6.1, §3.8.1, §3.8.3, §3.8.4, §4.2,
  §5.7.1, §8.1.2).
- Spec #19 `IN REVIEW` → blocks resolution of #19 citations
  (§3.3.5, §3.4.3, §3.5.3, §3.9.5, §4.3.1, §4.4, §5.7.2, §6.1,
  §6.3, §8.1.3).
- `certification-platform.md` Stage 0 row `_TBD_` → blocks first
  Stage 0+1 perf-gate activation (FR-PO-052; not a #18-approval
  blocker per KD-9 status caveat).

Resolution path (per §1.4 bidirectional sequencing):
1. #18 reaches `IN REVIEW` (this flip).
2. #16 reaches Tier 2 `APPROVED` (unlocks #16 `TBD-NORMATIVE`).
3. #19 reaches `APPROVED` (unlocks #19 `TBD-NORMATIVE`).
4. #18's `TBD-NORMATIVE` tags resolve and #18 advances to `APPROVED`.

## 9.5 Version History

| Version | Date         | Author      | Notes |
|---------|--------------|-------------|-------|
| 0.2     | May 14, 2026 | Claude Code | PASS-1 findings resolved: M-3 §9.4.1 #19 blocker list extended with §3.3.5/§3.4.3/§3.9.5 (ERR-018-007); M-7 SPEC_INDEX.md updated atomically to IN REVIEW with this v0.2 pass (ERR-018-011). |
| 0.1     | May 13, 2026 | Claude Code | Initial draft from `outline-detailed.md` v1.1 §9. Self-applicable checklist with KD-6 binding (every row cites file path or programmatic check). Appendix D survey scope decision recorded. `TBD-NORMATIVE` blocker list at §9.4.1 explicit for reviewer. Status flipped to `IN REVIEW` author-driven; lead-developer sign-off pending. |
